Table 2_Autologous and allogeneic hematopoietic cell transplantation in children and adult

A single-center study of 41 patients with high-risk anaplastic large cell lymphoma (ALCL) who underwent hematopoietic cell transplantation (HCT) between 1997 and 2020. The dataset, authored by Natalie L. Smith and shared on figshare, includes patient characteristics and outcomes to evaluate the role of disease status at transplant on survival. It reports 5-year progression-free and overall survival estimates for autologous (n=24) and allogeneic (n=17) HCT groups.

Use Cases

• Compare survival outcomes between autologous and allogeneic HCT based on the reported 5-year PFS and OS percentages.
• Analyze the impact of detectable disease at transplant on patient survival based on the described subgroup analysis.
• Investigate temporal trends in transplant outcomes using the data subset for procedures performed in 2009 or later.

Strengths

• Includes data on 41 patients with a clear temporal scope from 1997 to 2020.
• Reports specific survival statistics, including 5-year PFS and OS with 95% confidence intervals for distinct treatment groups.
• Explicitly compares outcomes based on a key clinical variable: detectable disease status prior to transplant.

Limitations

• Row count and column-level documentation are absent; field semantics must be inferred after download.
• The dataset's 62.1 KB size suggests a limited scope, likely containing summary statistics rather than individual patient records.
• Data is from a single center, which may limit generalizability.

Provenance

Source

Natalie L. Smith via figshare.

Collection Method

Data collected on patients treated at a single center.

Time Range

1997-2020

Freshness

Last updated 2026-04-22 11:44:27; freshness should be verified.